Literature DB >> 8807207

High-dose catecholamine treatment decreases polymorphonuclear leukocyte phagocytic capacity and reactive oxygen production.

C Wenisch1, B Parschalk, A Weiss, K Zedwitz-Liebenstein, B Hahsler, H Wenisch, A Georgopoulos, W Graninger.   

Abstract

Flow cytometry was used to study phagocytic function (uptake of fluorescein isothiocyanate-labeled bacteria) and release of reactive oxygen products (dihydrorhodamine 123 converted to rhodamine 123) following phagocytosis by neutrophil granulocytes of heparinized whole blood treated with adrenaline, noradrenaline, dopamine, dobutamine, or orciprenaline. Reduced neutrophil phagocytosis and reactive oxygen production were seen at 12 micrograms of adrenaline per liter (72% each compared with control values); at 120 micrograms of noradrenaline (72% each), dobutamine (83 and 80%, respectively), and orciprenaline (81 and 80%, respectively) per liter; and at 100 micrograms of dopamine per liter (66 and 70%) (P < 0.05 for all). At these dosages, neutrophil chemotaxis was reduced to < 50% of control values for all catecholamines. Treatment with catecholamines at lower dosages had no significant effect on phagocytosis or generation of reactive oxygen products or chemotaxis. The phagocytic capacity of granulocytes was related to the generation of reactive oxygen products (r = 0.789; P < 0.05). The results demonstrate that catecholamines have a suppressive effect on the response of phagocytic cells to bacterial pathogens at high therapeutic levels in blood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807207      PMCID: PMC170361          DOI: 10.1128/cdli.3.4.423-428.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  20 in total

Review 1.  Effects of cyclic nucleotides on granulocytes.

Authors:  R G Coffey
Journal:  Immunol Ser       Date:  1992

2.  Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate.

Authors:  H R Hill; R D Estensen; P G Quie; N A Hogan; N D Goldberg
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

3.  Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor.

Authors:  R N Spengler; R M Allen; D G Remick; R M Strieter; S L Kunkel
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

Review 4.  Tissue destruction by neutrophils.

Authors:  S J Weiss
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

5.  Rapid method for the isolation of neutrophils in high yield without the use of dextran or density gradient polymers.

Authors:  P Eggleton; R Gargan; D Fisher
Journal:  J Immunol Methods       Date:  1989-07-06       Impact factor: 2.303

6.  Direct and indirect effects of antibiotics on granulocyte activity.

Authors:  H Gnarpe; J Belsheim
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

7.  Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.

Authors:  A Severn; N T Rapson; C A Hunter; F Y Liew
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

8.  Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels.

Authors:  E Brandt; F Petersen; H D Flad
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

9.  Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock.

Authors:  M C Vespasiano; J R Lewandoski; J J Zimmerman
Journal:  Crit Care Med       Date:  1993-05       Impact factor: 7.598

10.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes.

Authors:  S Haskill; C Johnson; D Eierman; S Becker; K Warren
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

View more
  10 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 2.  [Effects of dopamine on cellular and humoral immune responses in septic patients].

Authors:  G Beck; C Hanusch; P Brinkkoetter; N Rafat; J Schulte; K van Ackern; B Yard
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

Review 3.  Role of neurons in the control of immune defense.

Authors:  Casandra Hoffman; Alejandro Aballay
Journal:  Curr Opin Immunol       Date:  2019-05-19       Impact factor: 7.486

Review 4.  Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum.

Authors:  Davide Tommaso Andreis; Mervyn Singer
Journal:  Intensive Care Med       Date:  2016-02-12       Impact factor: 17.440

Review 5.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

Review 6.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

7.  Norepinephrine-mediated suppression of phagocytosis by wound neutrophils.

Authors:  Ankush Gosain; Richard L Gamelli; Luisa A DiPietro
Journal:  J Surg Res       Date:  2008-06-02       Impact factor: 2.192

8.  Time-course evaluation of whole blood phagocytosis in mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  Haseeb Ahmad Khan
Journal:  Inflammopharmacology       Date:  2004       Impact factor: 4.473

Review 9.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

10.  Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline.

Authors:  Ana Paula Metran Nascente; Flávio Geraldo Rezende Freitas; Jan Bakker; Antônio Tonete Bafi; Renata Teixeira Ladeira; Luciano Cesar Pontes Azevedo; Alexandre Lima; Flavia Ribeiro Machado
Journal:  Clinics (Sao Paulo)       Date:  2017-12       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.